NeoBiocon FZ LLC

Keeping pace with trends towards collaborations that spur growth, Neopharma entered a joint venture with Asia’s premier biopharmaceutical company – Biocon, to form Neobiocon. With the last few years witnessing an increased momentum in the biopharma sector, this convergence aims to leverage mutual competencies and catalyze growth. Neopharma will form a critical part of the company’s horizontal integration process. Neobiocon is poised to become the biotech hub of the UAE, unifying biotechnology and nanotechnology products. This alliance brings forth specialised knowledge in manufacturing generics, address conditions that were previously untreatable and improve treatment outcomes.